On March 6, 2018 Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, reported that Bill Enright, President and Chief Executive Officer, will provide a corporate overview at the 30th Annual ROTH Conference and the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium (Press release, Altimmune, MAR 6, 2018, View Source [SID1234524432]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
30th Annual ROTH Conference Presentation Details
Date: Tuesday, March 13
Time: 7:00pm Eastern Time/4:00pm Pacific Time
Location: The Ritz Carlton Orange County, Newport Beach, California – Salon 6
B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium (CHIPS)
Date: Saturday, March 17
Time: 8:30am China Time/7:30pm Eastern Time – Room A
Location: Intercontinental Hotel, Hangzhou, China